- Home
- FCNCO vs HUMAW Comparison
FCNCO vs HUMAW Comparison
Compare FCNCO & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FCNCO | HUMAW |
|---|---|---|
| Founded | 1898 | 2004 |
| Country | United States | United States |
| Employees | 18141 | 184 |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | FCNCO | HUMAW |
|---|---|---|
| Price | $20.56 | $0.01 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 12.0K | ★ 35.9K |
| Earning Date | 10-23-2025 | 03-21-2025 |
| Dividend Yield | ★ 6.17% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 169.27 | N/A |
| Revenue | ★ $8,897,000,000.00 | N/A |
| Revenue This Year | $0.56 | N/A |
| Revenue Next Year | $2.24 | N/A |
| P/E Ratio | $0.12 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $20.05 | $0.00 |
| 52 Week High | $23.91 | $0.50 |
Technical Indicators
Market Signals| Indicator | FCNCO | HUMAW |
|---|---|---|
| Relative Strength Index (RSI) | 49.48 | 35.61 |
| Support Level | $20.55 | $0.01 |
| Resistance Level | $20.87 | $0.01 |
| Average True Range (ATR) | 0.13 | 0.00 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 45.00 | 4.76 |
Price Performance
Historical ComparisonAbout FCNCO First Citizens BancShares Inc. 5.625% Non-Cumulative Perpetual Preferred Stock Series C
First Citizens is a US regional bank with total assets of around $236 billion as of March 31, 2026. Headquartered in Raleigh, North Carolina, First Citizens' largest markets are North Carolina, South Carolina, and California. The bank has a track record of acquiring troubled banks from the FDIC, such as Silicon Valley Bridge Bank in 2023, which doubled its asset base. First Citizens offers products and services across retail, commercial, wealth management, and railcar leasing. First Citizens derived over 95% of its earnings from banking and less than 5% from railcar leasing in 2025.
About HUMAW Humacyte Inc. Warrant
Humacyte Inc is developing a commercial-stage biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.